MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.

Rodrigo Naves; Ana Maria Lennon; Giovanna Barbieri; Lilian Reyes; Gisella Puga; Laura Salas; Virginie Deffrennes; Mario Rosemblatt; Marc Fellous; Dominique Charron

doi:10.1093/intimm/14.5.481

MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.

Identifier:nobleid.org/w1/20260515/C64C2FCD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C64C2FCD.svg?ark=w1%2F20260515%2FC64C2FCD)](https://nobleid.org/work/w1/20260515/C64C2FCD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.

Identifier:nobleid.org/w1/20260515/C64C2FCD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/C64C2FCD.svg?ark=w1%2F20260515%2FC64C2FCD)](https://nobleid.org/work/w1/20260515/C64C2FCD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work